- And… We’re Back.
- Transitions
- Bioethical Marching Orders
- FDA Intervention Shelves Plan for Drugstore Genome Tests
- The Boons of an NIH Boost
- Crime Lab DNA Databases Under the Microscope
- Domes of Carbon Over U.S. Cities Damage Urban Health
- FDA Rules for Cigarettes Are a Victory for Public Health, for Science (and for the Earth’s Climate?)
- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Science Policy in the Science Times
Shinya Yamanaka’s work developing iPS cells puts Japan back on the map for basic medical research. A profile of one of the the scientists behind one of the biggest life-sciences breakthroughs of the year, and a window into the trial-and-error methods of complex lab work. It also mentions his plans to commercialize stem cell research for drug development, a potent avenue described in Kathryn Hinsch’s recent Science Progress article.
“Because the world now fights malaria—ineptly—with nets, insecticides and drugs, a vaccine is desperately needed.” Another inside-the-lab look at Sanaria Inc., which is working on a malaria vaccine made from whole irradiated parasites, rather than protein fragments. Founded with backing from the National Institute of Allergy and Infectious Diseases, the Army, and the Institute for One World Health, $29 million from the Gates Foundation ramped up research last year. Questions about the vaccine’s effectiveness, safety, and difficulty of storage and delivery remain.
Should states and cities distribute naloxone, which counteracts the effects of a heroin overdose, directly to addicts? Some public health officials point to existing programs that do so, citing drops in overdose death rates, and call the policy “a no-brainer”; the White House Office of National Drug Control Policy says there is insufficient data to support the conclusion.
“Peace can be defined as security and the secure access to resources that are essential for living,” said Rajendra K. Pachauri, chairman of the Intergovernmental Panel on Climate Change, accepting one-half of the Nobel Peace Prize on behalf of the organization, which shared the honor with former Vice President Al Gore.
Comments on this article
